Antibiotic resistance rises in India, ICMR report flags growing threat


Daijiworld Media Network - New Delhi

New Delhi, Nov 18: Antibiotics that have long been relied upon to treat common infections are increasingly failing against bacteria, with a new Indian Council of Medical Research (ICMR) report warning of rising antimicrobial resistance (AMR) across hospitals in India.

The ICMR's Antimicrobial Resistance Surveillance and Research Network (AMRSN) Annual Report 2025 highlights declining effectiveness of several commonly prescribed antibiotics against bacteria responsible for urinary tract infections, pneumonia, bloodstream infections and other serious illnesses. It also flags resistance to some of the stronger antibiotics used to treat complicated infections.

The report identifies Escherichia coli (E. coli) as a major concern and points to the spread of antimicrobial resistance beyond large tertiary-care hospitals, underlining the need for infection prevention alongside appropriate antibiotic treatment.

The surveillance covered 1,13,008 positive laboratory samples collected from 30 large specialised hospitals in 2025. For the first time, the report also incorporated data from 34 secondary-care hospitals, including 12 district hospitals, which contributed another 20,529 positive samples.

Among the bacteria identified in large hospitals, E. coli accounted for 24.4 per cent of samples, followed by Klebsiella pneumoniae at 16.9 per cent, Pseudomonas aeruginosa at 12.2 per cent and Acinetobacter baumannii at 9.5 per cent.

E. coli, which commonly lives in the intestines, can cause urinary tract infections and, in some cases, serious bloodstream and intestinal infections. Klebsiella pneumoniae is associated with pneumonia, urinary tract, bloodstream and wound infections, while Pseudomonas aeruginosa can cause severe infections, particularly among hospitalised patients. Acinetobacter baumannii is especially dangerous for critically ill patients.

The findings on E. coli are particularly concerning. Only 18.4 per cent of tested samples responded to cefotaxime and 24.7 per cent to ceftazidime, while susceptibility to ciprofloxacin stood at just nine per cent. The findings indicate that these commonly used antibiotics may be ineffective against a substantial proportion of E. coli infections.

Klebsiella pneumoniae also showed considerable resistance to carbapenems, a class of powerful antibiotics generally reserved for serious infections. Only 36.5 to 40.4 per cent of the tested samples remained susceptible to these medicines, with even poorer responses reported among intensive-care unit (ICU) samples.

One of the most alarming findings was that 91.1 per cent of tested Acinetobacter baumannii samples were resistant to carbapenems, severely limiting treatment options for patients with infections caused by the bacterium.

The report also recorded significant resistance in Staphylococcus aureus, with 56.8 per cent of tested samples showing resistance to methicillin. Resistance to other antibiotics, including linezolid, was also reported.

The inclusion of smaller hospitals provides a broader understanding of the AMR situation in the country. E. coli was commonly detected in secondary-care facilities, particularly in urine samples, while larger hospitals reported a wider range of pathogens, including higher proportions of Klebsiella, Pseudomonas and Acinetobacter.

The variations in bacterial prevalence and resistance patterns may reflect differences in patient profiles, severity of illness, healthcare exposure and local antibiotic use. The findings underline the importance of region-specific surveillance and treatment guidelines rather than relying on a uniform approach across hospitals.

However, the report also indicates that resistance is not uniform across all bacteria and antibiotics. Salmonella Typhi, which causes typhoid, continued to show susceptibility to several medicines, including azithromycin and ceftriaxone, although its susceptibility to ciprofloxacin remained extremely low.

Resistance among bacteria responsible for diarrhoeal infections was also significant. Only 7.5 per cent of Shigella flexneri samples and 8.9 per cent of Shigella sonnei samples were susceptible to ciprofloxacin. Among diarrhoeagenic E. coli, susceptibility to ciprofloxacin was just 0.7 per cent, while only 4.6 per cent responded to cefixime.

The findings caution against indiscriminate use of fluoroquinolone antibiotics for certain bacterial diarrhoeal infections. Doctors may need laboratory testing to identify the causative bacteria and determine the appropriate treatment, particularly in severe, persistent or complicated cases.

Antimicrobial resistance poses an especially serious threat to newborns and critically ill patients, who are vulnerable to infections and may require immediate treatment.

For the first time, the report has presented separate findings on bloodstream infections among newborns, infants and children. Among newborns aged up to 28 days, Klebsiella pneumoniae was the most frequently identified bacterium, accounting for 25.1 per cent of samples. Candida and Acinetobacter baumannii were also commonly detected.

Several bacteria responsible for neonatal infections showed poor susceptibility to commonly prescribed antibiotics, including third-generation cephalosporins. This poses significant challenges in treating neonatal sepsis, a potentially life-threatening infection that can spread through the bloodstream.

The findings highlight the importance of early diagnosis, timely laboratory testing and prompt initiation of appropriate treatment in newborns. When commonly used antibiotics fail, doctors may have to turn to alternative medicines, making responsible antibiotic use even more critical.

The report stresses that tackling antimicrobial resistance requires more than developing or prescribing stronger medicines. Hospitals must strengthen infection-prevention practices, including hand hygiene, proper sterilisation of medical instruments, cleaning of surfaces and equipment, and measures to prevent infections from spreading between patients.

Doctors also need access to reliable laboratory testing to identify pathogens and determine their susceptibility to antibiotics. Treatment should be guided by these findings wherever possible, with adjustments made when necessary.

Carbapenems and other last-resort antibiotics, in particular, need to be protected through responsible prescribing and appropriate use.

The growing resistance documented by the ICMR underscores the urgent need for coordinated action involving hospitals, doctors, laboratories, healthcare authorities and the public to ensure antibiotics remain effective for future generations.

 

 

  

Top Stories


Leave a Comment

Title: Antibiotic resistance rises in India, ICMR report flags growing threat



You have 2000 characters left.

Disclaimer:

Please write your correct name and email address. Kindly do not post any personal, abusive, defamatory, infringing, obscene, indecent, discriminatory or unlawful or similar comments. Daijiworld.com will not be responsible for any defamatory message posted under this article.

Please note that sending false messages to insult, defame, intimidate, mislead or deceive people or to intentionally cause public disorder is punishable under law. It is obligatory on Daijiworld to provide the IP address and other details of senders of such comments, to the authority concerned upon request.

Hence, sending offensive comments using daijiworld will be purely at your own risk, and in no way will Daijiworld.com be held responsible.